In addition to genes that were reported to be frequently mutated in previous genomic studies of NPC, such as TP53, BAP1, CYLD and NFKBIA, we also identified other SMGs, such as SIX2 and RPLP1 (Fig. 1c). This evidence concerns the gene TP53 and nasopharyngeal carcinoma.